Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4147668 | 0.89 | TLR7 (0.65) | TLR7TLR8 | |
| SCHEMBL20796975 | 0.85 | TLR7 (0.63) | TLR7TLR8 | |
| SCHEMBL22493483 | 0.84 | TLR7 (0.64) | TLR7TLR8 | |
| Acetic Acid SCHEMBL28392158 | 0.83 | TLR7 (0.67) | TLR7TLR8 | |
| Acetic Acid SCHEMBL22493481 | 0.82 | TLR7 (0.62) | TLR7TLR8 | |
| SCHEMBL29493231 | 0.81 | TLR7 (0.73) | TLR7TLR8 | |
| SCHEMBL483380 | 0.81 | TLR7 (0.61) | TLR7TLR8 | |
| SCHEMBL12756932 | 0.81 | TLR7 (0.58) | TLR7TLR8 | |
| SCHEMBL20806172 | 0.81 | TLR7 (0.69) | TLR7TLR8 | |
| SCHEMBL18587594 | 0.81 | TLR7 (0.75) | TLR7TLR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11267813-B2 | Substituted imidazoquinolines | BioNTech SE | 2022-03-08 | — | — | US | disclosed |
| US-20200317663-A1 | SUBSTITUTED IMIDAZOQUINOLINES | BioNTech SE (DE) | 2020-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200317663-A1 | SUBSTITUTED IMIDAZOQUINOLINES | TLR7, TLR3, TLR1 | TLR7 1/4885TLR8 8/4885 |
| US-11267813-B2 | Substituted imidazoquinolines | TLR7, TLR3, TLR1 | TLR7 1/4885TLR8 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.